[The risk of dihydroergotamine treatment in pregnancy].
D000328:Adult; D004087:Dihydroergotamine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D007752:Obstetric Labor, Premature / Q000139:chemically induced*; D010120:Oxytocics / Q000009:adverse effects; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D012306:Risk
D010120:Oxytocics; D004087:Dihydroergotamine
Uber das Risiko einer Dihydroergotamin-Behandlung in der Schwangerschaft.